The biotechnology company Cyclezyme announces that all 150,000 outstanding warrants have been exercised, providing the company with SEK 1.8 million before issuance costs. The subscription price amounted to SEK 12 per share.The dilution for shareholders who did not participate in the offering amounts to approximately 5.8 percent.